v3.25.2
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Class A shares
Common Stock
Iris
Class B common stock
Common Stock
Iris
Extension deposits due from sponsor
Iris
Additional Paid in Capital
Iris
Additional Paid in Capital
Accumulated Deficit
Iris
Accumulated Deficit
Iris
Total
Beginning balance at Dec. 31, 2022   $ 690   $ 140,000   $ (13,974,105)   $ (13,833,415)  
Balance at the beginning (in shares) at Dec. 31, 2022   6,900,000              
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A common stock to redemption amount           420,786   420,786  
Excise tax payable attributable to redemption of common stock           (103,587)   (103,587)  
Conversion of Class B common stock to Class A common stock $ 690 $ (690)              
Conversion of Class B common stock to Class A common stock (in shares) 6,900,000 (6,900,000)              
Net loss           (1,226,218) $ (4,984,000) (1,226,218) $ (4,984,000)
Ending balance at Dec. 31, 2023 $ 690     140,000   (14,883,124)   (14,742,434)  
Balance at the end (in shares) at Dec. 31, 2023 6,900,000                
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A common stock to redemption amount       (86,389)       (86,389)  
Excise tax payable attributable to redemption of common stock           (12,657)   (12,657)  
Recovery of excess redemptions - tax claim           294,669   294,669  
Net loss           (858,231) (1,754,000) (858,231) (1,754,000)
Ending balance at Mar. 31, 2024 $ 690     53,611   (15,459,343)   (15,405,042)  
Balance at the end (in shares) at Mar. 31, 2024 6,900,000                
Beginning balance at Dec. 31, 2023 $ 690     140,000   (14,883,124)   (14,742,434)  
Balance at the beginning (in shares) at Dec. 31, 2023 6,900,000                
Increase (Decrease) in Stockholders' Equity                  
Deemed contribution for extension deposit from Sponsor     $ (160,677) 160,677          
Remeasurement of Class A common stock to redemption amount       (248,882)       (248,882)  
Excise tax payable attributable to redemption of common stock           (25,421)   (25,421)  
Recovery of excess redemptions - tax claim           294,669   294,669  
Net loss         $ 0 (2,904,299) (3,546,000) (2,904,299) (3,546,000)
Ending balance at Dec. 31, 2024 $ 690   (160,677) 51,795   (17,518,175)   (17,626,367)  
Balance at the end (in shares) at Dec. 31, 2024 6,900,000                
Increase (Decrease) in Stockholders' Equity                  
Deemed contribution for extension deposit from Sponsor     (31,406) 31,406          
Remeasurement of Class A common stock to redemption amount       (37,585)       (37,585)  
Excise tax payable attributable to redemption of common stock           (7,024)   (7,024)  
Net loss           (891,382) $ (328,000) (891,382) $ (328,000)
Ending balance at Mar. 31, 2025 $ 690   $ (192,083) $ 45,616   $ (18,416,581)   $ (18,562,358)  
Balance at the end (in shares) at Mar. 31, 2025 6,900,000